Skip to main content
. 1999 Apr;1(1):23–30. doi: 10.1038/sj.neo.7900001

Figure 1.

Figure 1

Derivation of anoikis-resistant variants of IEC-18 cells. A. Experimental protocol (see text). B. Morphology of spheroids composed of IEC-18, AR1.10, AR2.10 or ras-3 cells after 48 hours in 3-dimensional culture. (Original magnification x 100) C. Cumulative survival curves (MTS assay) of anoikis resistant variants of IEC-18 cells derived by spheroid selection protocol (AR1.10, AR2.10) or transformation with mutant H-ras oncogene (ras-4).